KMBConsumer Defensive · Household & Personal ProductsThe 16 Wall Street analysts covering Kimberly-Clark Corp. hold a median 12-month price target of $115 — +5.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 66 of 100 as at 22 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Kimberly-Clark Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (94): The share price has been relatively steady.
Growth (23): Sales and profits are flat, shrinking, or growing more slowly than they were.
Size (7): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on KMB, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +5.2% from it.
Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 5 Aug 2026 | TD Cowen | Maintains | Hold | $96 → $104 |
| 5 Aug 2026 | UBS | Maintains | Neutral | $115 → $116 |
| 21 July 2026 | Barclays | Maintains | Equal-Weight | — |
| 21 July 2026 | Barclays | Maintains | Equal-Weight | $101 → $115 |
| 16 July 2026 | UBS | Maintains | Neutral | — |
| 16 July 2026 | UBS | Maintains | Neutral | $106 → $115 |
| 8 July 2026 | Wells Fargo | Maintains | Equal-Weight | $100 → $110 |
| 8 July 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 17 June 2026 | Piper Sandler | Maintains | Overweight | — |
| 29 Apr 2026 | UBS | Maintains | Neutral | — |
| 14 Apr 2026 | Barclays | Maintains | Equal-Weight | — |
| 10 Apr 2026 | B of A Securities | Maintains | Buy | — |
| 8 Apr 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 7 Apr 2026 | UBS | Maintains | Neutral | — |
| 30 Mar 2026 | Deutsche Bank | Maintains | Hold | — |
| 13 Mar 2026 | Piper Sandler | Maintains | Overweight | — |
| 28 Jan 2026 | UBS | Maintains | Neutral | — |
| 14 Jan 2026 | Citigroup | Maintains | Sell | — |
| 14 Jan 2026 | UBS | Maintains | Neutral | — |
| 8 Jan 2026 | TD Cowen | Maintains | Hold | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. KMB appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 36% of US stocks
Cheaper than 51% of US stocks
Cheaper than 5% of US stocks
Cheaper than 32% of US stocks
Higher than 29% of US stocks
Higher than 15% of US stocks
Higher than 48% of US stocks
Higher than 78% of US stocks
Higher than 73% of US stocks
Higher than 96% of US stocks
Higher than 92% of US stocks
Higher than 82% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Kimberly-Clark Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The article discusses Kimberly-Clark's Powering Care strategy, which is driving sustained volume and mix growth, supported by new fiber innovation that strengthens its long-term growth pipeline.
Why it matters — KMB watchers would care because the Powering Care strategy and fiber innovation appear to be supporting the company's ongoing growth momentum.
Kimberly-Clark (KMB) lowered its 2026 outlook, citing disruption in the China diaper market that is weighing on growth. The company noted that productivity gains and favorable volume-mix effects offer some offsetting support.
Why it matters — The reduced 2026 guidance points to ongoing pressure from China diaper market disruption, a key factor for investors tracking KMB's growth prospects.
Kimberly-Clark shares have risen 15.4% over the past three months, reflecting stronger productivity and volume-mix trends that have driven momentum in its transformation efforts. However, conditions in China and slower overall growth remain risks to the company.
Why it matters — A KMB watcher would care because the recent share-price gain points to improving productivity and volume-mix trends, even as challenges in China and slower growth temper the outlook.
Zacks Investment Research examined whether Kimberly-Clark (KMB) is worth buying given its low valuation. The piece notes that KMB's valuation discount and productivity gains support the bull case, while China disruption and slower category growth weigh on its outlook.
Why it matters — A KMB watcher would care because the report balances supportive valuation and productivity strengths against China-related disruption and slower category growth that could shape the company's outlook.
Kimberly-Clark appointed Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will report to Jeff Melucci and join the company's Executive Leadership Team.
Why it matters — The addition of an experienced legal executive to the leadership team signals a focus on enterprise risk management and strategic guidance as the company pursues its next phase of growth.
The 16 Wall Street analysts covering Kimberly-Clark Corp. have a median 12-month price target of $115, with estimates ranging from $90 to $162. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 16 analysts covering Kimberly-Clark Corp., 7 rate it a Buy, 8 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Kimberly-Clark Corp. 66 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, Kimberly-Clark Corp. ranks 66 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (94 of 100).
No one can know that. What the data says: the median 12-month target from 16 analysts implies +5.2% from the last close, and Ticker Nerd's factor model ranks Kimberly-Clark Corp. 66 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Kimberly-Clark Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for KMB are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $90 to $162 over the next 12 months.
Kimberly-Clark Corp. returned -13.9% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Kimberly-Clark Corporation is a global consumer goods company specializing in essential personal care and tissue products for everyday use. Headquartered in Dallas, Texas, it focuses on categories such as baby and child care, adult incontinence, feminine care, family care, and professional hygiene solutions.
The most recent item we track (Zacks Investment Research, 19 Aug 2026): "Can Kimberly-Clark's Powering Care Strategy Sustain Growth Momentum?". The article discusses Kimberly-Clark's Powering Care strategy, which is driving sustained volume and mix growth, supported by new fiber innovation that strengthens its long-term growth pipeline.
Kimberly-Clark Corporation is a global consumer goods company specializing in essential personal care and tissue products for everyday use. Headquartered in Dallas, Texas, it focuses on categories such as baby and child care, adult incontinence, feminine care, family care, and professional hygiene solutions. The company manufactures items made primarily from natural and synthetic fibers, leveraging nonwoven and absorbency technologies to produce disposable diapers, training and youth pants, baby wipes, feminine and incontinence care products, as well as facial and bathroom tissue, paper towels, napkins, wipes, soaps, and sanitizers. Kimberly-Clark markets its products under widely recognized brands including Huggies, Kleenex, Scott, Cottonelle, Kotex, Depend, Poise, Andrex, Pull-Ups, GoodNites, Viva, and WypAll, serving consumers, healthcare providers, and businesses across more than 175 countries. Distribution spans supermarkets, mass merchandisers, drugstores, warehouse clubs, department stores, professional distributors, and e-commerce channels, positioning Kimberly-Clark as a key player in global hygiene and tissue markets. Founded in 1872, the company today operates with a strong presence in both consumer and professional segments worldwide.
CEO Mr. Michael D. Hsu · 36,000 employees · United States · https://www.kimberly-clark.com